Strabismus (also known as heterotropia or, in the UK, as squint) is a condition in which the two eyes are misaligned; that is, both eyes do not look at the same place at the same time (for the American Optometric Association definition, see
https://www.aoa.org/healthy-eyes/eye-and-vision-conditions/strabismus?sso=y). The degree of misalignment comes in a broad range of sizes, ranging from just a few degrees (microstrabismus) to very large angles, and in various directions—with one eye deviating inward (esotropia), outward (exotopia), up (hypertropia), or down (hypotropia) or rotated inward or outward around the visual axis (cyclotropia). The misalignment can be constant or intermittent (for example, only when fatigued) and can present at all viewing distances or only under specific viewing conditions—for example, only when looking up close (
Duke-Elder, 1973). If strabismus occurs late in life (e.g., due to trauma or stroke), it results in diplopia, because the object of interest will be imaged on the fovea of one eye and on a non-corresponding area in the other. However, if the strabismus has its onset early in life, this results in suppression (inhibition) of the deviated eye. The locus and nature of the suppression depend on the direction of the eye turn. Conventional treatments include realigning the eyes using glasses (lenses and/or prisms), exercises (orthoptics), or surgery to realign the eyes. Classically, orthoptic treatment (also known as vision therapy) was often done using a clinical Wheatstone mirror stereoscopic arrangement (known as a troposcope, synoptophore, or amblyoscope) (
Figure 1, left). This allows separate images to be presented to the two eyes (an example is shown in
Figure 1, top right) and alignment of the images on corresponding areas in the two eyes by adjusting the positions of the mirrors to enable fusion. In addition, the troposcope is used to try to reduce suppression, encourage fusion and stereopsis, and increase the range of fusional vergence. These functions can be (and have been) readily achieved in XR display devices; an example is the VIVE Pro Eye head-mounted display (HMD) shown in
Figure 1, bottom right. Although there are many smartphone apps developed exclusively for ophthalmological purposes—as many as 131 as of March 2020 (
Aruljyothi, Janakiraman, Malligarjun, & Babu, 2021), with several aimed at treating amblyopia—they are not well suited to treating binocular vision anomalies because of limitations due to the small size of the (single) screen.